Anzeige
Mehr »
Login
Freitag, 20.05.2022 Börsentäglich über 12.000 News von 667 internationalen Medien
Neue Studie veröffentlicht - Auf den Spuren von Boehringer Ingelheim!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB ISIN: FR0011049824 Ticker-Symbol: 4ZG 
Frankfurt
20.05.22
08:14 Uhr
10,220 Euro
-0,120
-1,16 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
10,80010,84016:24

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.05.Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device170Median has received the FDA's feedback following the 513(g) regulatory submission for its iBiopsy LCS CADe/CADx Software as Medical Device. Median will proceed through a 510(k) submission...
► Artikel lesen
03.05.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2022173Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
21.04.Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022201Record high revenue of €5.7 million in Q1 2022, up 9.2% compared with Q1 2021 Further growth in the order backlog to €62.3 million as of March 31, 2022, up 18.4% compared with March 31...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
08.04.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2022294Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
25.03.Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022269Regulatory News: Median Technologies (ALMDT:PA) (Paris:ALMDT) announces today that the company will publish its 2021 annual results on April 21, 2022 after trading. The 2021 annual results publication...
► Artikel lesen
22.03.Median Technologies Announces Design Completion of its iBiopsy Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance209iBiopsy Lung Cancer Screening (LCS) CADe/CADx1outstanding performance reaches 94.7% sensitivity2 at 93.3% specificity3, based on a cohort of 1,760 patients With such performance, iBiopsy...
► Artikel lesen
09.03.Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2022199Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
03.03.Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device207513(g) submission is a key milestone that marks the initiation of Median's interactions with the FDA. 513(g) submission will allow Median Technologies to determine the best FDA regulatory...
► Artikel lesen
01.03.Median Technologies to Participate in the Cowen's 42nd Annual Health Care Conference206Regulatory News: Median Technologies (Paris: ALMDT), will be participating in the Cowen's 42nd Annual Health Care Conference, taking place virtually on March 7-9, 2022. Fredrik Brag, Median's...
► Artikel lesen
08.02.Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2022245Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
17.01.Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million259Revenue of €20.5 million as of December 31, 2021, up 52% versus 2020 (€13.5 million). Order backlog growth to €58 million as of December 31, 2021. Cash and cash equivalents of €39...
► Artikel lesen
14.01.Median Technologies: Half Year Liquidity Contract Statement384Regulatory News: Under the liquidity contract entrusted by Median Technologies (Paris:ALMDT) (FR0011049824 ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account...
► Artikel lesen
10.01.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2021250Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
05.01.Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy Lung Cancer Screening354iBiopsy Lung Cancer Screening (LCS) detection performance reaches 94.9% sensitivity for a false positive rate of 1 per CT scan, a performance superior to that of lung CADe systems currently on...
► Artikel lesen
04.01.Median Technologies: Financial Communications Schedule for the First Half of 2022262Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA), announces the publication date for its 2021 results: Publication Date 2021 results April 26, 2022* ...
► Artikel lesen
06.12.21Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2021252Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
23.11.21Median Technologies Announces New Outstanding Performance for its iBiopsy Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization345iBiopsy's Lung Cancer Screening performance (LCS) for stage 1 lung cancer reaches 93.1% sensitivity at 96.2% specificity. These results are critical for lung cancer characterization at...
► Artikel lesen
08.11.21Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2021276Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
21.10.21Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators313Business continues to grow at a sustained pace in the first half of 2021 Two highly impactful announcements for iBiopsy and iCRO business units during Q3, 2021 Third quarter revenue...
► Artikel lesen
13.10.21Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021280Regulatory News: Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on October 25th, 2021 at 6:00 pm CEST during...
► Artikel lesen
Seite:  Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1